Stay updated with breaking news from Saama Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Funds led by Carlyle have acquired a majority stake in Saama Technologies, according to a news release. The investment is valued at up to $430 million.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Drug development advancements call for skilled workforce According to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes. Suresh Katta, CEO and founder of Saama Technologies, spoke with Outsourcing-Pharma about the rapid technological advancements in the drug development field, and how companies can cultivate a workforce capable of keeping up. OSP: Could you please talk about some of the shifts in and demands on the clinical trial industry that are changing what we expect of st...
Posted on Goa Institute of Management has secured its place among the top 15 private business schools in the country. With programs known for their intensity which are designed to equip the students to face workplaces dotted with excellent performers and achievers, a GIM graduate is supposed to be a multi-tasking individual, a leader, team worker and a change maker. With acute importance given to a multi faceted development programme including summer internships, social responsibilities GIM saw a successful round of placements in the grey year of 2020-21. The ...
Saama, Oracle partner on integrated clinical trial technology Saama’s range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development. Saama Technologies is collaborating with Oracle to integrate Saama’s smart applications with the Oracle Health Sciences Clinical One platform. The collaboration is intended to enable pharmaceutical companies and their research partners to harness artificial intelligence (AI)-driven insights to expedite clinical trials. Saama chief strategy officer Sag...